The metastatic potential of OS cells is correlated with aldehyde dehydrogenase 1A1 (ALDH1A1) activity [221] and overexpression is associated with poor cancer prognosis in some cancers [222] and resistance to doxorubicin and cisplatin therapy in vitro [223]. Here, ALDH1A1 is linked to cancer.